Global sales approach the half-trillion mark

Article Abstract:

Global Pharmaceutical Industry sales growth, forecasts and trends, drug costs and pricing etc., have been described. The various stages for drug starting from laboratory to acceptance of drug by FDA in the United States, grant of patent and its subsequent expiry, entry of generic drugs etc., have also been described. Government's investments in research and development of medicines, its expenditure in health care sectors and general determinants to be used while assessing a pharmaceutical company have been provided.

Product standards, safety, & recalls, Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Product information, Marketing procedures, Government regulation, Pharmaceutical Preparation Manufacturing, Commodity & service prices, Drugs, Pharmaceutical Preparations, Metabolic Agents NEC, Metabolic Agents, Standards, Prices and rates, Marketing, Testing, Licensing, certification and accreditation, Company marketing practices, United States. Food and Drug Administration, Company pricing policy

---

Industry profile: global drug sales moderating

Article Abstract:

An analysis on the performance by various countries in terms of their pharmaceutical industry is presented for the year 2004 is presented. While North America ranked on the top position grabbing a share of 53%, United States was at the second position. A statistical discussion on the financial and sales performance of various United States companies is also presented. The forecast for the near future seems to become slow in terms of the industry's growth.

Market share, Company market share, Industry forecasts

---

Worldwide sales exceed $430 billion

Article Abstract:

The records of a market research firm reported an estimated total global pharmaceuticals sales of $433 billion from 12 months through June 2003. The changing trends in the industry, it's functioning and its stock performance statistics are discussed for further forecasting and investment analysis of the global pharmaceutical market.

Global economy

Similar abstracts:

• Abstracts: Social workers in the ED tackle many problems. On-the-job training vital supplement to degree. The new finance department: CQI triggers big changes in role
• Abstracts: Employee participation programs in the healthcare industry: are they unlawful under recent labor rulings? Sexual harassment at work: issues and answers for health care administrators
• Abstracts: How the industry operates. Industry consolidation continues unabated
• Abstracts: Hospital response to prospective payment: moral hazard, selection, and practice-style effects. Hospital quality choice and market structure in a regulated duopoly
• Abstracts: How the industry operates. Business and strategy

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.